PI3K, phosphatidylinositol 3-kinase; PKC, Protein kinase C; PLC, Phospholipase C; TF,Tissue Factor; TNFα, Tumor Necrosis Factor α; VPS, vacuolar protein sorting; VAMP, Vesicle associated membrane ...
The current PI3K 3C inhibitors in use in advanced breast cancer are alpelisib and inavolisib. Capivasertib is an AKT inhibitor, which is also used in PI3K 3C mutated breast cancer. So these are ...
Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.
Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. There are several clinical trials ...
January is in the books, and markets are still waiting on a big rebound in the dealmaking space. Investors rooting for increased M&A and a flurry of IPOs will have to be patient as Q1 tracks with ...
January is in the books, and markets are still waiting on a big rebound in the dealmaking space. Investors rooting for increased M&A and a flurry of IPOs will have to be patient as Q1 tracks with ...
Expert Rev Clin Pharmacol. 2012;5(3):319-336. Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its ...
1 Department of Breast and Thyroid Surgery, Shaoxing People’s Hospital, Shaoxing, China 2 Department of Medical Research Center, Shaoxing People’s Hospital, Shaoxing, China Breast cancer remains a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results